MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$692K
Net Income
-$31,849K
Net Profit Margin
-4602.46%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
    • Net product and licensing revenu...
    • Royalties and other revenue
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
692
21,102
5,493
14,182
Cost of sales
39
108
201
10
Research and development
17,443
12,756
11,314
18,757
Selling, general and administrative, including stock-based compensation of 1,952, 1,575, 3,661, and 3,044 respectively
9,750
9,234
8,759
7,602
Total operating expenses
27,232
22,098
20,274
26,369
(loss) income from operations
-26,540
-996
-14,781
-12,187
Interest and other expense
2,609
1,590
2,031
2,155
Interest and other income
1,723
1,543
1,283
1,573
Gain (loss) on extinguishment of debt
-4,349
-
-
-
Net loss
-31,775
-1,043
-15,529
-12,769
Unrealized gain on investments
-74
-160
1
43
Comprehensive (loss) income
-31,849
-1,203
-15,528
-12,726
Basic EPS
-0.07
0
-0.043
-0.04
Diluted EPS
-0.07
0
-0.043
-0.04
Basic Average Shares
437,653,000
400,240,000
363,446,000
363,399,000
Diluted Average Shares
437,653,000
400,240,000
363,170,000
363,399,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive (loss) income-$31,849K (-1091.25%↓ Y/Y)Net loss-$31,775K (-1077.09%↓ Y/Y)Unrealized gain oninvestments-$74K (-89.74%↓ Y/Y)Interest and other income$1,723K (-6.05%↓ Y/Y)Net product andlicensing...$680K (-48.56%↓ Y/Y)Royalties and otherrevenue$12K (loss) income fromoperations-$26,540K (-810.39%↓ Y/Y)Gain (loss) onextinguishment of debt-$4,349K Interest and otherexpense$2,609K (12.55%↑ Y/Y)Total revenues$692K (-97.60%↓ Y/Y)Total operatingexpenses$27,232K (8.36%↑ Y/Y)Research and development$17,443K (10.77%↑ Y/Y)Selling, general andadministrative, including...$9,750K (4.28%↑ Y/Y)Cost of sales$39K (18.18%↑ Y/Y)

LEXICON PHARMACEUTICALS, INC. (LXRX)

LEXICON PHARMACEUTICALS, INC. (LXRX)